Last updated 2026-07-30
TL;DR
Topical dapsone gel (Aczone) reduces inflammatory acne lesions by roughly 30-50% over 12 weeks in FDA trials, working slower and more subtly than "before and after" photos online suggest. Oral dapsone can clear skin conditions too, but it requires G6PD blood testing first because it can cause hemolytic anemia in deficient patients. The two forms have almost nothing in common risk-wise.
What does a real dapsone before and after actually look like?
Most people picture a dramatic split-screen photo: red, cystic skin on one side, clear skin two weeks later on the other. That's not what the clinical trial data shows for topical dapsone, and resetting expectations before you spend money on it matters. In the two main Phase 3 trials that got Aczone 5% gel approved by the FDA, patients used the gel twice daily for 12 weeks. By the end, roughly 40-50% of inflammatory lesions had cleared, and investigator-rated "success" (meaning skin rated clear or almost clear) hit somewhere around 15-20% higher than the vehicle (placebo gel) group [1]. That's a real effect, but it's gradual. Nobody wakes up on day 10 with clear skin. The more concentrated Aczone 7.5% gel, approved in 2016 and dosed once daily, showed similar modest-but-real improvement over 12 weeks in its own trials, with global acne severity improving in a minority but meaningful share of patients compared to vehicle [2]. If you're chasing an actual before/after transformation, think weeks 4 through 12, not days. For a walk through what happens week by week, the dapsone first month what to expect guide breaks down the early phase, which is mostly about tolerating the product and waiting, not seeing dramatic change yet.
How much acne improvement do the clinical trials actually show?
| Inflammatory lesion reduction | ~41-46% | ~30-33% | |
|---|---|---|---|
| Global Acne Assessment Score success | Higher, statistically significant | Lower | Source: FDA-reviewed trial data summarized in Aczone prescribing information [1] A later trial of Aczone 7.5% (once-daily) found similar direction of effect: modest but statistically significant improvement over vehicle in both lesion counts and global severity ratings at week 12 [2]. Nobody has published head-to-head trials comparing dapsone gel directly against benzoyl peroxide or topical retinoids, so we can't honestly rank it against those options on hard data alone. For the full breakdown of clearance percentages across studies, see dapsone success rate. And if you want other people's subjective experience layered on top of the trial numbers, dapsone reviews collects that. |
The published numbers are modest, not miraculous. This matters because a lot of before-and-after content online implies near-total clearing, and that's not what the trials found. In the original Aczone 5% trials (Draelos et al., published in support of the 2005 FDA approval), inflammatory lesion counts dropped by about 41-46% in the dapsone groups versus about 30-33% in the vehicle (inactive gel) groups over 12 weeks [1]. Total lesion count reductions were in a similar range. The difference between drug and placebo is real but not huge, which is typical for topical acne agents generally, not a dapsone-specific weakness. | Trial endpoint (12 weeks) | Aczone 5% gel | Vehicle gel |
How long does it take to see results with topical dapsone?
Plan on 8 to 12 weeks minimum before judging whether it's working, with the first month largely being about your skin adjusting rather than clearing. The FDA-reviewed trials measured outcomes at 12 weeks, which is the standard runway dermatologists use for any topical acne treatment [1] [2]. Some people notice less redness and fewer new lesions forming by week 4 to 6. Full assessment, though, really needs the full three months. If you stop at week 3 because you don't see a transformation, you're stopping before the drug had a chance to work. The dapsone results timeline page has the week-by-week expectations mapped out in more detail if you want to track your own progress against what the trials measured.
Does dapsone gel work for cystic or hormonal acne?
The trial populations were mostly people with mild to moderate inflammatory acne, not severe cystic acne, so the honest answer is: dapsone gel probably helps some inflammatory component, but it's not positioned or tested as a primary treatment for deep cystic nodules. Dapsone's acne mechanism is thought to be anti-inflammatory and mildly antimicrobial rather than hormonal, so it doesn't address androgen-driven cystic acne the way spironolactone or oral contraceptives might [3]. Dermatologists commonly use it as an add-on to retinoids or oral antibiotics for moderate inflammatory acne rather than a monotherapy for severe cystic disease. If your acne is mostly deep, painful nodules, dapsone gel alone is unlikely to be the whole answer, and you should ask about combination therapy.
What about oral dapsone, is that used for skin conditions too?
Yes, but it's a different drug story entirely, and this is the distinction that matters most in this whole topic. Oral dapsone is a sulfone antibiotic that's been used for decades for leprosy (Hansen's disease) and Pneumocystis pneumonia prevention, and off-label for skin conditions like dermatitis herpetiformis, where it's actually a first-line treatment recognized in dermatology literature [4]. It's also used for some cases of severe, treatment-resistant inflammatory skin disease. It is not a standard treatment for ordinary acne, and no major guideline recommends oral dapsone as an acne therapy. The reason it works well for dermatitis herpetiformis is specific: it directly suppresses the neutrophil-driven inflammation in that condition, often improving itching within 24 to 72 hours, which is much faster than its topical acne effect [4]. That fast, strong effect comes with meaningfully higher systemic risk than the topical gel. This is the single biggest confusion point in dapsone content online. People search "dapsone before and after" expecting acne photos, find oral dapsone forums for dermatitis herpetiformis, and mentally merge the two risk profiles. Don't do that.
Why does oral dapsone require G6PD testing before you start it?
Because oral dapsone can trigger serious, sometimes life-threatening hemolytic anemia in people with G6PD (glucose-6-phosphate dehydrogenase) deficiency, and prescribers are expected to screen for it first. G6PD deficiency is a genetic enzyme deficiency that makes red blood cells vulnerable to oxidative stress. Dapsone's metabolites cause oxidative damage to red blood cells in essentially everyone taking it, and in G6PD-deficient patients that damage is severe enough to cause acute hemolysis [5]. The FDA-approved prescribing information for oral dapsone states plainly that patients should be tested for G6PD deficiency before starting therapy, and that hemolysis and hemolytic anemia occur in a dose-related fashion even in normal patients, more severely in deficient ones [6]. G6PD deficiency affects an estimated 400 million people worldwide and is more common in people of African, Mediterranean, Middle Eastern, and Southeast Asian ancestry, according to the CDC [5]. In the US, it's estimated to affect roughly 1 in 10 African American males to some degree [5]. This isn't a rare edge case screening protocol, it's a genuinely common genetic trait, which is exactly why the screening step is non-negotiable rather than optional caution. Beyond hemolysis, oral dapsone carries risk of methemoglobinemia (reduced oxygen-carrying capacity in blood), agranulocytosis (dangerous drop in white blood cells), and dapsone hypersensitivity syndrome, a rare but serious reaction involving fever, rash, and organ involvement that can appear weeks after starting the drug [6]. None of these are theoretical footnotes. They're listed in the boxed warning and adverse reaction sections of the drug label.
Does topical dapsone gel need G6PD testing too?
No, and this is one of the clearest wins for the topical form. FDA labeling for Aczone gel explicitly states that clinically significant hemolysis has not been observed in trials, and G6PD testing is not required before starting it [1]. Systemic absorption of dapsone through the skin is low. Pharmacokinetic studies cited in the Aczone prescribing information found blood dapsone levels after topical use are a small fraction of what oral dosing produces, low enough that the hematologic risks seen with oral dapsone essentially don't materialize with the gel [1]. That's the core reason dermatologists consider Aczone a low-risk topical option while treating oral dapsone as a specialty drug requiring lab monitoring. That said, some mild lab changes have shown up in subgroups even with topical use, so if you have known G6PD deficiency, mention it to your prescriber anyway. "Not required" isn't the same as "impossible to matter," it's a real risk-tier difference, not a guarantee of zero effect.
What side effects show up in the topical dapsone before and after story?
The most commonly reported side effects in trials were mild and local: dryness, redness, and peeling at the application site, plus an oily or orange-ish skin discoloration when benzoyl peroxide is used at the same time (a known interaction, not a sign anything is wrong) [1] [1]. Systemic side effects were uncommon. In trial data, rates of headache and nasal irritation were reported at low single-digit percentages, similar to or only slightly above vehicle group rates [1]. This tracks with the low systemic absorption point above. It's a reasonably well-tolerated topical, which is a big part of why it's an easy add-on to other acne routines rather than a drug people quit over side effects. For the fuller weighing of benefits against downsides and cost, dapsone pros and cons covers that ground, and is dapsone worth it tackles the value question directly if you're deciding whether to start.
Can you use dapsone gel with benzoyl peroxide or retinoids?
Yes, dapsone gel is commonly combined with both, but the benzoyl peroxide combination causes a well-documented cosmetic quirk: temporary yellow or orange skin discoloration where the two products overlap [1] [1]. This discoloration is not dangerous and washes off, but it surprises people who weren't warned about it. Using the products at different times of day (for example, retinoid at night, dapsone in the morning, or vice versa) is a common workaround dermatologists suggest, though it's a practical tip rather than something tested in a formal trial. Combining topical dapsone with a retinoid has no similar reported interaction issue in the prescribing information.
How do topical and oral dapsone compare on risk overall?
| FDA-approved use | Acne vulgaris [1] [2] | Leprosy, dermatitis herpetiformis, PCP prophylaxis (off-label for some skin disease) [4] [6] | |
|---|---|---|---|
| G6PD testing required | No [1] | Yes [6] | |
| Hemolytic anemia risk | Not clinically significant in trials [1] | Documented, dose-related [6] | |
| Methemoglobinemia risk | Not established as a concern | Documented risk [6] | |
| Agranulocytosis risk | Not reported | Documented, rare but serious [6] | |
| Dapsone hypersensitivity syndrome | Not reported with topical use | Documented, can be fatal [6] | |
| Typical monitoring | None routine | Baseline G6PD, periodic blood counts | Source: FDA prescribing information for Aczone gel [1] and oral dapsone [6] If a friend asked me point blank: for acne, use the topical gel and don't worry much about the scary oral dapsone risks you read about, they don't apply here. For dermatitis herpetiformis or other conditions where a doctor is actually recommending oral dapsone, get the G6PD test first, no exceptions, and expect ongoing blood work. |
They shouldn't be compared as if they're the same drug on a dial, because the routes of administration create fundamentally different exposure and risk. | Factor | Topical dapsone (Aczone gel) | Oral dapsone |
Is dapsone before and after content on social media reliable?
Treat it skeptically. Before-and-after posts rarely disclose lighting changes, makeup, concurrent treatments (a lot of people layering dapsone with a retinoid, a new cleanser, and diet changes all at once), or the actual timeframe between photos. The clinical trial numbers above (roughly 40-50% inflammatory lesion reduction over 12 weeks, modestly better than vehicle) are the most reliable baseline you have, because they come from controlled conditions with a placebo comparison [1] [2]. A single influencer's dramatic clearing might be real, might be multiple products working together, or might be selective photo choice. None of that is dishonest necessarily, it's just not data. Where topical dapsone fits into a provider-reviewed treatment plan, including how prescriptions get filled through Dapsone Rx's pharmacy partner network, is worth discussing directly with a prescriber who can also confirm whether a G6PD check makes sense for your specific health history.
Frequently asked questions
How fast does dapsone gel work for acne?
Clinical trials measured results at 12 weeks, and that's the realistic timeframe to judge it by. Some reduction in redness or new breakouts may appear by weeks 4-6, but full assessment needs the full 12-week course used in FDA trials for both the 5% and 7.5% gel formulations [1][2].
Does dapsone gel bleach clothes or hair like benzoyl peroxide?
No, dapsone gel itself isn't reported to bleach fabric the way benzoyl peroxide does. The known cosmetic issue is a temporary yellow-orange skin discoloration when combined with benzoyl peroxide on the skin itself, not a bleaching effect on clothing [1][8].
Do I need a blood test before starting topical dapsone for acne?
No. FDA labeling for Aczone gel states G6PD testing is not required because clinically significant hemolysis hasn't been observed in trials, due to low systemic absorption through skin [8]. This is different from oral dapsone, which does require G6PD testing before starting.
Why does oral dapsone require a G6PD test but topical doesn't?
Oral dapsone reaches much higher blood levels and its metabolites cause oxidative stress on red blood cells throughout the body, which is dangerous in G6PD-deficient patients [5][6]. Topical gel absorbs into the bloodstream at much lower levels, so that systemic hemolytic risk doesn't meaningfully appear in trial data [8].
What is G6PD deficiency and how common is it?
G6PD deficiency is a genetic enzyme deficiency that leaves red blood cells vulnerable to oxidative damage from certain drugs, including oral dapsone. The CDC estimates it affects roughly 1 in 10 African American males in the US, and is also common in people of Mediterranean, Middle Eastern, and Southeast Asian descent [7].
Can dapsone gel clear cystic acne completely?
Unlikely as a standalone treatment. Trial populations were mostly mild to moderate inflammatory acne, and dapsone's mechanism is anti-inflammatory rather than hormonal, so it doesn't target the androgen-driven processes behind deep cystic nodules the way spironolactone or hormonal therapy can [1][3].
Is oral dapsone ever used for acne?
Not as a standard or guideline-recommended treatment. Oral dapsone is FDA-approved for leprosy and used off-label for dermatitis herpetiformis and some severe skin diseases, but it isn't a typical acne therapy given its systemic risks (hemolysis, methemoglobinemia, agranulocytosis) [4][6].
What percentage of acne lesions clear with Aczone in clinical trials?
Trials for Aczone 5% gel found roughly 41-46% reduction in inflammatory lesions over 12 weeks, versus about 30-33% with vehicle (placebo) gel, a meaningful but not dramatic difference [1]. The 7.5% once-daily formulation showed a similar pattern of modest improvement over vehicle [2].
What are the warning signs of dapsone hypersensitivity syndrome?
It typically presents with fever, rash, and swollen lymph nodes, sometimes weeks after starting oral dapsone, and can involve liver or other organ damage. It's listed as a serious adverse reaction in the oral dapsone prescribing information and is a reason for close monitoring, not something to ignore if symptoms appear [6].
Can you use dapsone gel and a retinoid together?
Yes, this combination is commonly used and doesn't have the same discoloration interaction seen with benzoyl peroxide. Many dermatologists pair dapsone gel with a retinoid for broader acne coverage, since the mechanisms differ (anti-inflammatory versus cell turnover) [1].
How long until side effects from dapsone gel go away?
Local side effects like dryness, redness, or peeling at the application site are usually mild and often ease within the first few weeks as skin adjusts, similar to the adjustment period seen with many topical acne treatments in trial data [1][8].
Is Aczone the same drug as oral dapsone?
The active ingredient (dapsone) is chemically the same, but the formulation, dose, and route are entirely different, and so is the risk profile. Aczone is a topical gel with low systemic absorption and no G6PD testing requirement; oral dapsone is a systemic antibiotic requiring blood monitoring [6][8].
Sources
- FDA, Aczone (dapsone) Gel 5% prescribing information / trial summary: 12-week trial data showing inflammatory lesion reduction and Global Acne Assessment Score results for Aczone 5% gel
- FDA, Aczone (dapsone) Gel 7.5% approval and prescribing information: Once-daily 7.5% gel trial results showing modest improvement over vehicle at 12 weeks
- American Academy of Dermatology, Guidelines of care for acne vulgaris management: Topical dapsone's role and mechanism relative to hormonal acne therapies in acne treatment guidelines
- National Institutes of Health / StatPearls, Dermatitis Herpetiformis: Oral dapsone as first-line treatment for dermatitis herpetiformis and its rapid symptom relief
- CDC, G6PD Deficiency fact sheet: Mechanism of G6PD deficiency and vulnerability of red blood cells to oxidative stress
- FDA, Dapsone tablets USP prescribing information: Requirement for G6PD testing before oral dapsone therapy and listed risks of hemolytic anemia, methemoglobinemia, agranulocytosis, and dapsone hypersensitivity syndrome